KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Prepaid Assets (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Prepaid Assets for 15 consecutive years, with $65.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 81.02% to $65.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $65.3 million, a 81.02% increase, with the full-year FY2025 number at $65.3 million, up 81.02% from a year prior.
  • Prepaid Assets was $65.3 million for Q4 2025 at Supernus Pharmaceuticals, up from $62.1 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $65.3 million in Q4 2025 to a low of $15.8 million in Q4 2022.
  • A 5-year average of $29.7 million and a median of $25.9 million in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: tumbled 48.25% in 2024, then surged 126.53% in 2025.
  • Supernus Pharmaceuticals' Prepaid Assets stood at $27.0 million in 2021, then tumbled by 41.6% to $15.8 million in 2022, then increased by 5.68% to $16.7 million in 2023, then skyrocketed by 116.41% to $36.1 million in 2024, then surged by 81.02% to $65.3 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Prepaid Assets are $65.3 million (Q4 2025), $62.1 million (Q3 2025), and $31.4 million (Q2 2025).